您当前的位置：
首页 >
文章列表页 >
Salmonella enterica mediated epigenetic promotion of fibrosis is a novel factor in benign prostatic hyperplasia
RESEARCH | 更新时间：2025-12-13
上一篇|下一篇

    • Salmonella enterica mediated epigenetic promotion of fibrosis is a novel factor in benign prostatic hyperplasia

    • Salmonella enterica mediated epigenetic promotion of fibrosis is a novel factor in benign prostatic hyperplasia

    • “专家们报告了良性前列腺增生（BPH）领域的最新研究，建立了微生物存在与前列腺纤维化之间的新联系。该研究为解决当前BPH治疗的无效性提供了解决方案，证实肠沙门氏菌通过ALKBH5-m6A-GPX4介导的铁下垂促进前列腺纤维化，为构建新的治疗靶点和个性化策略奠定了基础。”
    • Cong Zhu ，Lu-Yao Li ，Ming-Hui Shi ，Cheng Fang ，Lu Yang ，Ting Li ，Fei Li ，Shi-Song Yang ，Tian-Kun Wang ，Dao-Jing Ming ，Tong Deng ，Hao-Yue Sun ，Wen-Ting Li ，Jia Zhang ，Yu-Sen Zhang ，Zhi-Yuan Jian ，Chang-Jiang Qin ，Shuang-Ying Wang ，Xian-Tao Zeng
    • Military Medical Research 2025年12卷第9期 页码：1350-1368

    • DOI： 10.1186/s40779-025-00614-2     

      中图分类号：

    • 录用：2025-04-29 ，

    移动端阅览

  •  
  •  

  • AI导读

  • HTML全文

  • 图( 7 ) 表( 0 )

  • 参考文献

  • 出版信息

  • 数据统计

65

浏览量

23

下载量

0

CSCD

文章被引用时，请邮件提醒。
提交
工具集
  • BibTeX下载
  • Endnote下载
  • RefMan 下载
  • NoteExpress下载
  • NoteFirst下载

相关文章

Global burden of benign prostatic hyperplasia, urinary tract infections, urolithiasis, bladder cancer, kidney cancer, and prostate cancer from 1990 to 2021
P. gingivalis in oral-prostate axis exacerbates benign prostatic hyperplasia via IL-6/IL-6R pathway
GPR65 as a potential novel therapeutic target for the treatment of hepatic fibrosis
Expression of transforming growth factor β receptors in CCI4, -induced cirrhotic liver in rats
Immune microenvironment dynamics in pregnant patients with concomitant autoimmune diseases: mechanisms, challenges, and clinical significance

相关作者

Xian-Tao Zeng
Shuang-Ying Wang
Chang-Jiang Qin
Zhi-Yuan Jian
Xian-Tao Zeng
Yu Fan
Tong-Zu Liu
Hang Zheng

相关机构

Department of Urology, Institute of Urology, Peking University First Hospital, Peking University, The National Urological Cancer Center of China
Evidence-Based Medicine Center, Xiangyang No. 1 People’s Hospital, Hubei University of Medicine
Department of Urology, Wuhan Clinical Research Center of Tumors of the Urinary System and Male Genital Organs, Hubei Key Laboratory of Urinary System Diseases, Zhongnan Hospital of Wuhan University
Department of Urology, Wuhan Third Hospital, Tongren Hospital of Wuhan University
Department of Forensic Medicine, Zhongnan Hospital of Wuhan University